Wencai Ma
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Hematology 11
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 5
- Genetics 7
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- R. Eric DavisZhiqiang WangMichael AndreeffRobert Z. OrlowskiMarina KonoplevaSergej KonoplevJatin J. ShahMichael Wang
- Journals
- Blood (12 papers)Bioinformatics (3 papers)Molecular Cancer Therapeutics (1 paper)Microbial Pathogenesis (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesChinaAustria
In The Last Decade
Wencai Ma
38 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 86
- Hematology 490
- Immunology 570
- Oncology 535
- Genetics 184
- Molecular Biology 872
Countries citing papers authored by Wencai Ma
This map shows the geographic impact of Wencai Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wencai Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wencai Ma more than expected).
Fields of papers citing papers by Wencai Ma
This network shows the impact of papers produced by Wencai Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wencai Ma. The network helps show where Wencai Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Wencai Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 8 | |
| 4 | 2020 | 2 | |
| 5 | 2018 | 44 | |
| 6 | 2018 | 1 | |
| 7 | 2015 | 30 | |
| 8 | 2015 | 95 | |
| 9 | 2014 | 5 | |
| 10 | 2014 | 3 | |
| 11 | 2014 | 228 | |
| 12 | 2013 | 356 | |
| 13 | 2012 | 31 | |
| 14 | 2012 | 55 | |
| 15 | 2012 | 143 | |
| 16 | 2010 | 15 | |
| 17 | 2010 | 35 | |
| 18 | 2010 | 97 | |
| 19 | 2009 | 12 | |
| 20 | 2009 | 3 |
About Wencai Ma
Wencai Ma is a scholar working on Hematology, Genetics, Immunology, Oncology and Cancer Research, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bioinformatics and Genomic Networks (7 papers), Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (5 papers), Ubiquitin and proteasome pathways (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Hematology (490 citations), Immunology (570 citations), Oncology (535 citations), Genetics (184 citations) and Molecular Biology (872 citations). Wencai Ma has collaborated with scholars based in United States, China and Austria. Frequent co-authors include R. Eric Davis, Zhiqiang Wang, Michael Andreeff, Robert Z. Orlowski, Marina Konopleva, Sergej Konoplev, Jatin J. Shah, Michael Wang, Deborah J. Kuhn and Chad C. Bjorklund. Their work appears in journals such as Blood, Bioinformatics, Molecular Cancer Therapeutics, Microbial Pathogenesis and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.